Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.

Biol Blood Marrow Transplant. 2019 May 24. pii: S1083-8791(19)30327-1. doi: 10.1016/j.bbmt.2019.05.016. [Epub ahead of print]

PMID:
31129353
2.

A computational solution to improve biomarker reproducibility during long-term projects.

Feng F, Thompson MP, Thomas BE, Duffy ER, Kim J, Kurosawa S, Tashjian JY, Wei Y, Andry C, Stearns-Kurosawa DJ.

PLoS One. 2019 Apr 17;14(4):e0209060. doi: 10.1371/journal.pone.0209060. eCollection 2019.

3.

Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation.

Nakashima T, Tanaka T, Koido K, Nishibuchi Y, Hashimoto H, Ito A, Inamoto Y, Kurosawa S, Kim SW, Fukuda T, Terakado H.

Int J Hematol. 2019 Jun;109(6):694-699. doi: 10.1007/s12185-019-02637-7. Epub 2019 Mar 26.

PMID:
30915718
4.

Capsule Endoscopy after Hematopoietic Stem Cell Transplantation Can Predict Transplant-Related Mortality.

Inoki K, Kakugawa Y, Takamaru H, Sekiguchi M, Matsumoto M, Matsuda T, Ito A, Tanaka T, Inamoto Y, Fuji S, Kurosawa S, Kim SW, Fukuda T, Ohe Y, Saito Y.

Digestion. 2019 Mar 22:1-10. doi: 10.1159/000498846. [Epub ahead of print]

PMID:
30904916
5.

Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission.

Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Ann Hematol. 2019 Mar 21. doi: 10.1007/s00277-019-03668-0. [Epub ahead of print] No abstract available.

PMID:
30899981
6.

Immunosuppressive effect of a non-proteinogenic amino acid from Streptomyces through inhibiting allogeneic T cell proliferation.

Yashiro T, Sakata F, Sekimoto T, Shirai T, Hasebe F, Matsuda K, Kurosawa S, Suzuki S, Nagata K, Kasakura K, Nishiyama M, Nishiyama C.

Biosci Biotechnol Biochem. 2019 Jun;83(6):1111-1116. doi: 10.1080/09168451.2019.1591262. Epub 2019 Mar 22.

PMID:
30898076
7.

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges.

Makita S, Imaizumi K, Kurosawa S, Tobinai K.

Drugs Context. 2019 Feb 13;8:212567. doi: 10.7573/dic.212567. eCollection 2019. Review.

8.

Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Yuda S, Fuji S, Onishi A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Fukuda T.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1152-1157. doi: 10.1016/j.bbmt.2019.01.011. Epub 2019 Jan 17.

PMID:
30660773
9.

Unusual manifestation of disseminated herpes simplex virus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocytic lymphohisitocytosis without genital involvement.

Kurosawa S, Sekiya N, Fukushima K, Ikeuchi K, Fukuda A, Takahashi H, Chen F, Hasegawa H, Katano H, Hishima T, Setoguchi K.

BMC Infect Dis. 2019 Jan 17;19(1):65. doi: 10.1186/s12879-019-3721-0.

10.

Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens.

Yasuda S, Najima Y, Konishi T, Yamada Y, Takezaki T, Kurosawa S, Sakaguchi M, Harada K, Yoshioka K, Igarashi A, Inamoto K, Toya T, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Sekiya N, Ohashi K.

J Infect Chemother. 2019 May;25(5):371-375. doi: 10.1016/j.jiac.2018.11.011. Epub 2019 Jan 11.

PMID:
30642772
11.

Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.

Kaito S, Toya T, Yoshifuji K, Kurosawa S, Inamoto K, Takeshita K, Suda W, Kakihana K, Honda K, Hattori M, Ohashi K.

Blood Adv. 2018 Nov 27;2(22):3097-3101. doi: 10.1182/bloodadvances.2018024968. No abstract available.

12.

Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions.

Shingai N, Kaito S, Yamada Y, Konishi T, Nagata A, Kurosawa S, Watakabe-Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Transpl Infect Dis. 2019 Feb;21(1):e13023. doi: 10.1111/tid.13023. Epub 2018 Nov 29.

PMID:
30407701
13.

Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2.

Tsuchiya S, Sawada S, Takeda K, Takahashi K, Nakajima T, Kohata M, Kurosawa S, Satake C, Imai J, Kikuchi K, Aiba S, Katagiri H.

Endocr J. 2019 Jan 28;66(1):107-114. doi: 10.1507/endocrj.EJ18-0356. Epub 2018 Nov 2.

14.

Thermotaxis in Chlamydomonas is brought about by membrane excitation and controlled by redox conditions.

Sekiguchi M, Kameda S, Kurosawa S, Yoshida M, Yoshimura K.

Sci Rep. 2018 Oct 31;8(1):16114. doi: 10.1038/s41598-018-34487-4.

15.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Blood Adv. 2018 Oct 23;2(20):2744-2754. doi: 10.1182/bloodadvances.2018020305.

16.

Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Fujisawa S, Onishi Y, Yano S, Onizuka M, Kanda Y, Mizuno I, Taniguchi S, Yamashita T, Inamoto Y, Okamoto S, Atsuta Y.

Bone Marrow Transplant. 2019 Apr;54(4):611-615. doi: 10.1038/s41409-018-0343-x. Epub 2018 Oct 4. No abstract available.

PMID:
30287939
17.

Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.

Kato Y, Hin N, Maita N, Thomas AG, Kurosawa S, Rojas C, Yorita K, Slusher BS, Fukui K, Tsukamoto T.

Eur J Med Chem. 2018 Nov 5;159:23-34. doi: 10.1016/j.ejmech.2018.09.040. Epub 2018 Sep 18.

PMID:
30265959
18.

Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients.

Ito R, Inamoto Y, Inoue Y, Ito A, Tanaka T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Yamashita T, Fukuda T.

Biol Blood Marrow Transplant. 2019 Feb;25(2):293-300. doi: 10.1016/j.bbmt.2018.09.014. Epub 2018 Sep 19.

PMID:
30244104
19.

Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis.

Hall G, Kurosawa S, Stearns-Kurosawa DJ.

Infect Immun. 2018 Oct 25;86(11). pii: e00530-18. doi: 10.1128/IAI.00530-18. Print 2018 Nov.

20.

Severe immune-related complications early after allogeneic hematopoietic cell transplantation for nivolumab-pretreated lymphoma.

Kuno M, Ito A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Fukuda T.

Bone Marrow Transplant. 2019 Mar;54(3):473-476. doi: 10.1038/s41409-018-0310-6. Epub 2018 Aug 21. No abstract available.

PMID:
30131507
21.

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.

Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T; Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group.

Blood Adv. 2018 Aug 14;2(15):1901-1913. doi: 10.1182/bloodadvances.2018020966.

22.

Latent environment allocation of microbial community data.

Higashi K, Suzuki S, Kurosawa S, Mori H, Kurokawa K.

PLoS Comput Biol. 2018 Jun 6;14(6):e1006143. doi: 10.1371/journal.pcbi.1006143. eCollection 2018 Jun.

23.

Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.

Fuji S, Kurosawa S, Inamoto Y, Murata T, Fuji T, Kim SW, Fukuda T.

Bone Marrow Transplant. 2019 Feb;54(2):304-307. doi: 10.1038/s41409-018-0223-4. Epub 2018 May 24. No abstract available.

PMID:
29795423
24.

Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.

Terada K, Yamaguchi H, Ueki T, Usuki K, Kobayashi Y, Tajika K, Gomi S, Kurosawa S, Saito R, Furuta Y, Miyadera K, Tokura T, Marumo A, Omori I, Sakaguchi M, Fujiwara Y, Yui S, Ryotokuji T, Arai K, Kitano T, Wakita S, Fukuda T, Inokuchi K.

Genes Chromosomes Cancer. 2018 Aug;57(8):401-408. doi: 10.1002/gcc.22542.

PMID:
29663558
25.

Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation.

Kurosawa S, Toya T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Leuk Lymphoma. 2018 Dec;59(12):3006-3009. doi: 10.1080/10428194.2018.1441410. Epub 2018 Apr 4. No abstract available.

PMID:
29616841
26.

Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.

Inoue Y, Fuji S, Tanosaki R, Inamoto Y, Tanaka T, Ito A, Okinaka K, Kurosawa S, Kim SW, Nakagama H, Fukuda T.

Bone Marrow Transplant. 2018 Sep;53(9):1105-1115. doi: 10.1038/s41409-018-0139-z. Epub 2018 Mar 9.

PMID:
29523883
27.

[Japan Marrow Donor Program and its coordinating process: current situations].

Hirakawa T, Kurosawa S, Tajima K, Yamazaki Y, Ikeda N, Kojima H, Tanaka H, Kanamori H, Miyamura K, Kodera Y, Fukuda T, Program JMD.

Rinsho Ketsueki. 2018;59(2):153-160. doi: 10.11406/rinketsu.59.153. Japanese.

PMID:
29515066
28.

Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.

Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1521-1526. doi: 10.1016/j.bbmt.2018.02.004. Epub 2018 Feb 21.

PMID:
29476953
29.

The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia.

Ochi K, Fuji S, Takano K, Tajima K, Ito A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Tojo A, Fukuda T.

Bone Marrow Transplant. 2018 Aug;53(8):1019-1029. doi: 10.1038/s41409-018-0115-7. Epub 2018 Feb 19.

PMID:
29459664
30.

Microfluidic detection of movements of Escherichia coli for rapid antibiotic susceptibility testing.

Kara V, Duan C, Gupta K, Kurosawa S, Stearns-Kurosawa DJ, Ekinci KL.

Lab Chip. 2018 Feb 27;18(5):743-753. doi: 10.1039/c7lc01019b.

31.

Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.

Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, Yamasaki S, Inoue Y, Moriuchi Y, Choi I, Ogata M, Hidaka M, Yamaguchi T, Fukuda T.

Bone Marrow Transplant. 2018 Jul;53(7):905-908. doi: 10.1038/s41409-017-0082-4. Epub 2018 Jan 25. No abstract available.

PMID:
29371687
32.

Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources.

Shichijo T, Fuji S, Tajima K, Kubo H, Nozaki K, Honda T, Yamaguchi J, Kawashima I, Kawajiri A, Takemura T, Onishi A, Ito A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Fukuda T.

Bone Marrow Transplant. 2018 May;53(5):634-639. doi: 10.1038/s41409-017-0045-9. Epub 2018 Jan 15. No abstract available.

PMID:
29335624
33.

[Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].

Kurosawa S, Sekiya N, Muraosa Y, Kamei K, Nagata A, Yamada Y, Konishi T, Takezaki T, Kaito S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2017;58(12):2375-2379. doi: 10.11406/rinketsu.58.2375. Japanese.

PMID:
29332869
34.

Pilot study: The application of a multicomponent exercise for older people in a depopulated rural area.

Kume Y, Fujita T, Sasaki A, Kurosawa S, Sato A, Uemura S, Inomata S, Megumi T, Nakamura Y.

Geriatr Gerontol Int. 2017 Dec;17(12):2639-2640. doi: 10.1111/ggi.13151. No abstract available.

PMID:
29265747
35.

A multi-center prospective study randomizing the use of fat emulsion in intensive glucose control after allogeneic hematopoietic stem cell transplantation using a myeloablative conditioning regimen.

Fuji S, Kim SW, Kamiya S, Nakane T, Matsumoto K, Onishi Y, Yakushijin K, Yamazaki E, Hino M, Kurosawa S, Yoshimura KI, Fukuda T.

Clin Nutr. 2018 Oct;37(5):1534-1540. doi: 10.1016/j.clnu.2017.08.022. Epub 2017 Nov 16.

PMID:
29187302
36.

Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital.

Obara S, Kurosawa S, Honda J, Oishi R, Iseki Y, Murakawa M.

J Clin Anesth. 2018 Feb;44:62-63. doi: 10.1016/j.jclinane.2017.11.003. Epub 2017 Nov 14. No abstract available.

PMID:
29145023
37.

Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Kawashima I, Inamoto Y, Maeshima AM, Nomoto J, Tajima K, Honda T, Shichijo T, Kawajiri A, Takemura T, Onishi A, Ito A, Tanaka T, Fuji S, Kurosawa S, Kim SW, Maruyama D, Tobinai K, Kobayashi Y, Fukuda T.

Biol Blood Marrow Transplant. 2018 Feb;24(2):294-300. doi: 10.1016/j.bbmt.2017.10.013. Epub 2017 Oct 14.

38.

Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor.

Terada K, Yamaguchi H, Ueki T, Usuki K, Kobayashi Y, Tajika K, Gomi S, Kurosawa S, Miyadera K, Tokura T, Omori I, Marumo A, Fujiwara Y, Yui S, Ryotokuji T, Osaki Y, Arai K, Kitano T, Kosaka F, Wakita S, Tamai H, Fukuda T, Inokuchi K.

Ann Hematol. 2018 Jan;97(1):51-61. doi: 10.1007/s00277-017-3143-2. Epub 2017 Oct 4.

PMID:
28980058
39.

Long-term follow-up clinics after hematopoietic cell transplantation: its needs and challenges in Japan.

Kurosawa S.

Rinsho Ketsueki. 2017;58(10):2111-2123. doi: 10.11406/rinketsu.58.2111. Japanese.

PMID:
28978856
40.

Effects of indigo carmine intravenous injection on oxygen reserve index (ORi™) measurement.

Isosu T, Yoshida K, Oishi R, Imaizumi T, Iseki Y, Sanbe N, Ikegami Y, Obara S, Kurosawa S, Murakawa M.

J Clin Monit Comput. 2018 Aug;32(4):693-697. doi: 10.1007/s10877-017-0064-5. Epub 2017 Oct 3.

PMID:
28975476
41.

Pneumococcal polysaccharide vaccination in allogeneic hematopoietic stem cell transplantation recipients: a prospective single-center study.

Okinaka K, Akeda Y, Kurosawa S, Fuji S, Tajima K, Oishi K, Fukuda T.

Microbes Infect. 2017 Nov;19(11):553-559. doi: 10.1016/j.micinf.2017.08.005. Epub 2017 Sep 29.

PMID:
28965937
42.

Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation.

Ikeuchi K, Doki N, Takao A, Hishima T, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Intern Med. 2017 Dec 1;56(23):3215-3217. doi: 10.2169/internalmedicine.8646-16. Epub 2017 Sep 25.

43.

Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.

Harada K, Sekiya N, Konishi T, Nagata A, Yamada Y, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Sasaki S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

BMC Infect Dis. 2017 Sep 22;17(1):638. doi: 10.1186/s12879-017-2745-6.

44.

Shiga Toxin Therapeutics: Beyond Neutralization.

Hall G, Kurosawa S, Stearns-Kurosawa DJ.

Toxins (Basel). 2017 Sep 19;9(9). pii: E291. doi: 10.3390/toxins9090291. Review.

45.

The impact of gender on medical visit communication and patient satisfaction within the Japanese primary care context.

Noro I, Roter DL, Kurosawa S, Miura Y, Ishizaki M.

Patient Educ Couns. 2018 Feb;101(2):227-232. doi: 10.1016/j.pec.2017.08.001. Epub 2017 Aug 2.

PMID:
28823411
46.

D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.

Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Fukunaga K, Wakita S, Ryotokuji T, Fukuda T, Inokuchi K.

Ann Hematol. 2017 Oct;96(10):1641-1652. doi: 10.1007/s00277-017-3074-y. Epub 2017 Jul 31.

PMID:
28762080
47.

Sudden blindness as an initial manifestation of localized fusariosis in ethmoid sinus and optic nerve.

Kurosawa S, Doki N, Sekiya N, Ikuta S, Takaki Y, Ohashi K.

Ann Hematol. 2017 Oct;96(10):1771-1772. doi: 10.1007/s00277-017-3080-0. Epub 2017 Jul 27. No abstract available.

PMID:
28752393
48.

Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.

Yanada M, Mori J, Aoki J, Harada K, Mizuno S, Uchida N, Kurosawa S, Toya T, Kanamori H, Ozawa Y, Ogawa H, Henzan H, Iwato K, Sakura T, Ota S, Fukuda T, Ichinohe T, Atsuta Y, Yano S.

Leuk Lymphoma. 2018 Mar;59(3):601-609. doi: 10.1080/10428194.2017.1357173. Epub 2017 Jul 28.

PMID:
28750566
49.

Clinical Utility of Wilms' Tumor 1 Monitoring in Patients with Myeloid Malignancy and Prior Allogeneic Hematopoietic Stem Cell Transplantation.

Ino K, Fuji S, Tajima K, Tanaka T, Okinaka K, Inamoto Y, Kurosawa S, Kim SW, Katayama N, Fukuda T.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1780-1787. doi: 10.1016/j.bbmt.2017.06.007. Epub 2017 Jun 30.

50.

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1749-1758. doi: 10.1016/j.bbmt.2017.06.011. Epub 2017 Jun 29.

Supplemental Content

Loading ...
Support Center